EWP
RDY icon

Elevation Wealth Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Elevation Wealth Partners’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-628
Closed -$9.1K – 1397
2026
Q2 		$9.1K Buy
+628
New +$8.47K ﹤0.01% 832

Other funds holding RDY

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Elevation Wealth Partners's RDY Position: Q3 2026 in Review

Elevation Wealth Partners sold out of Dr. Reddy's Laboratories (RDY) in Q3 2026, closing a stake of 628 shares — an estimated $9.1K sold.

Elevation Wealth Partners first reported a position in RDY in Q2 2026 and held it in 1 quarter. The position peaked at $9.1K in Q2 2026. 5 funds tracked by Wall St. Rank hold RDY as of Q3 2026.

  • Elevation Wealth Partners reported no remaining Dr. Reddy's Laboratories position as of Q3 2026 after selling out during the quarter.
  • Elevation Wealth Partners sold 628 Dr. Reddy's Laboratories shares in Q3 2026, an estimated $9.1K.
  • Elevation Wealth Partners first reported a position in Dr. Reddy's Laboratories in Q2 2026 and held it in 1 quarter.
  • Elevation Wealth Partners's Dr. Reddy's Laboratories position peaked at $9.1K in Q2 2026.
  • 5 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.